-
1
-
-
59649124237
-
Integrating biological knowledge with gene expression profiles for survival prediction of cancer
-
Chen X., Wang L. Integrating biological knowledge with gene expression profiles for survival prediction of cancer. J. Comput. Biol. 2009, 16:265-278.
-
(2009)
J. Comput. Biol.
, vol.16
, pp. 265-278
-
-
Chen, X.1
Wang, L.2
-
2
-
-
41449118564
-
Overexpression of CDC2/CyclinB1 in gliomas, and CDC2 depletion inhibits proliferation of human glioma cells in vitro and in vivo
-
Chen H., Huang Q., Dong J., Zhai D.Z., Wang A.D., Lan Q. Overexpression of CDC2/CyclinB1 in gliomas, and CDC2 depletion inhibits proliferation of human glioma cells in vitro and in vivo. BMC Cancer 2008, 8:1-11.
-
(2008)
BMC Cancer
, vol.8
, pp. 1-11
-
-
Chen, H.1
Huang, Q.2
Dong, J.3
Zhai, D.Z.4
Wang, A.D.5
Lan, Q.6
-
3
-
-
77951749300
-
Id2 promotes tumor cell migration and invasion through transcriptional repression of semaphorin 3F
-
Coma S., Amin D.N., Shimizu A., Lasorella A., Iavarone A., Klagsbrun M. Id2 promotes tumor cell migration and invasion through transcriptional repression of semaphorin 3F. Cancer Res. 2010, 70:3823-3832.
-
(2010)
Cancer Res.
, vol.70
, pp. 3823-3832
-
-
Coma, S.1
Amin, D.N.2
Shimizu, A.3
Lasorella, A.4
Iavarone, A.5
Klagsbrun, M.6
-
4
-
-
35649020482
-
Gene expression profile as a prognostic factor in high-grade gliomas
-
Czernicki T., Zegarska J., Paczek L., Cukrowska B., Grajkowska W., Zajaczkowska A., et al. Gene expression profile as a prognostic factor in high-grade gliomas. Int. J. Oncol. 2007, 30:55-64.
-
(2007)
Int. J. Oncol.
, vol.30
, pp. 55-64
-
-
Czernicki, T.1
Zegarska, J.2
Paczek, L.3
Cukrowska, B.4
Grajkowska, W.5
Zajaczkowska, A.6
-
5
-
-
4644313275
-
Gene expression profiling of gliomas strongly predicts survival
-
Freije W.A., Castro-Vargas F.E., Fang Z., Horvath S., Cloughesy T., Liau L.M., et al. Gene expression profiling of gliomas strongly predicts survival. Cancer Res. 2004, 64:6503-6510.
-
(2004)
Cancer Res.
, vol.64
, pp. 6503-6510
-
-
Freije, W.A.1
Castro-Vargas, F.E.2
Fang, Z.3
Horvath, S.4
Cloughesy, T.5
Liau, L.M.6
-
6
-
-
61849096150
-
MiR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: an essential role for apoptosis
-
Guo C.J., Pan Q., Li D.G., Sun H., Liu B.W. miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: an essential role for apoptosis. J. Hepatol. 2009, 50:766-778.
-
(2009)
J. Hepatol.
, vol.50
, pp. 766-778
-
-
Guo, C.J.1
Pan, Q.2
Li, D.G.3
Sun, H.4
Liu, B.W.5
-
7
-
-
18344366398
-
Towards a molecular classification of gliomas
-
Hoang-Xuan K., Idbaih A., Mokhtari K., Sanson M. Towards a molecular classification of gliomas. Bull. Cancer 2005, 92:310-316.
-
(2005)
Bull. Cancer
, vol.92
, pp. 310-316
-
-
Hoang-Xuan, K.1
Idbaih, A.2
Mokhtari, K.3
Sanson, M.4
-
8
-
-
37549029742
-
Functional interaction of E1AF and Sp1 in glioma invasion
-
Jiang J., Wei Y., Shen J., Liu D., Chen X., Zhou J., et al. Functional interaction of E1AF and Sp1 in glioma invasion. Mol. Cell. Biol. 2007, 27:8770-8782.
-
(2007)
Mol. Cell. Biol.
, vol.27
, pp. 8770-8782
-
-
Jiang, J.1
Wei, Y.2
Shen, J.3
Liu, D.4
Chen, X.5
Zhou, J.6
-
9
-
-
0035420014
-
Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles
-
Kihara C., Tsunoda T., Tanaka T., Yamana H., Furukawa Y., Ono K., et al. Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles. Cancer Res. 2001, 61:6474-6479.
-
(2001)
Cancer Res.
, vol.61
, pp. 6474-6479
-
-
Kihara, C.1
Tsunoda, T.2
Tanaka, T.3
Yamana, H.4
Furukawa, Y.5
Ono, K.6
-
10
-
-
0033772866
-
Molecular analysis of the PTEN TP53 and CDKN2A tumor suppressor genes in long-term survivors of glioblastoma multiforme
-
Kraus J.A., Glesmann N., Beck M., Krex D., Klockgether T., Schackert G., et al. Molecular analysis of the PTEN TP53 and CDKN2A tumor suppressor genes in long-term survivors of glioblastoma multiforme. J. Neurooncol. 2000, 48:89-94.
-
(2000)
J. Neurooncol.
, vol.48
, pp. 89-94
-
-
Kraus, J.A.1
Glesmann, N.2
Beck, M.3
Krex, D.4
Klockgether, T.5
Schackert, G.6
-
11
-
-
0034135920
-
Expression of p19INK4d, CDK4 CDK6 in glioblastoma multiforme
-
Lam P.Y., Di Tomaso E., Ng H.K., Pang J.C., Roussel M.F., Hjelm N.M. Expression of p19INK4d, CDK4 CDK6 in glioblastoma multiforme. Br. J. Neurosurg. 2000, 14:28-32.
-
(2000)
Br. J. Neurosurg.
, vol.14
, pp. 28-32
-
-
Lam, P.Y.1
Di Tomaso, E.2
Ng, H.K.3
Pang, J.C.4
Roussel, M.F.5
Hjelm, N.M.6
-
12
-
-
68249139757
-
Prognostic factors influencing clinical outcomes of glioblastoma multiforme
-
Li S.W., Qiu X.G., Chen B.S., Zhang W., Ren H., Wang Z.C., et al. Prognostic factors influencing clinical outcomes of glioblastoma multiforme. Chin. Med. J. (Engl.) 2009, 122:1245-1249.
-
(2009)
Chin. Med. J. (Engl.)
, vol.122
, pp. 1245-1249
-
-
Li, S.W.1
Qiu, X.G.2
Chen, B.S.3
Zhang, W.4
Ren, H.5
Wang, Z.C.6
-
13
-
-
20244387732
-
Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma muItiforme
-
Liang Y., Diehn M., Watson N., Bollen A.W., Aldape K.D., Nicholas M.K., et al. Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma muItiforme. Proc. Natl. Acad. Sci. U. S. A. 2005, 19:5814-5819.
-
(2005)
Proc. Natl. Acad. Sci. U. S. A.
, vol.19
, pp. 5814-5819
-
-
Liang, Y.1
Diehn, M.2
Watson, N.3
Bollen, A.W.4
Aldape, K.D.5
Nicholas, M.K.6
-
14
-
-
51249093386
-
Access to immunology through the gene ontology
-
Lovering R.C., Camon E.B., Blake J.A., Diehl A.D. Access to immunology through the gene ontology. Immunology 2008, 125:154-160.
-
(2008)
Immunology
, vol.125
, pp. 154-160
-
-
Lovering, R.C.1
Camon, E.B.2
Blake, J.A.3
Diehl, A.D.4
-
17
-
-
33847669866
-
Prognosis factors of survival time in patients with glioblastoma multiforme: a multivariate analysis of 340 patients
-
Mineo J.F., Bordron A., Baroncini M., Ramirez C., Maurage C.A., Blond S., et al. Prognosis factors of survival time in patients with glioblastoma multiforme: a multivariate analysis of 340 patients. Acta Neurochir. (Wien.) 2007, 149:245-252.
-
(2007)
Acta Neurochir. (Wien.)
, vol.149
, pp. 245-252
-
-
Mineo, J.F.1
Bordron, A.2
Baroncini, M.3
Ramirez, C.4
Maurage, C.A.5
Blond, S.6
-
18
-
-
0025719036
-
Multidrug resistance gene (MDR1) expression in human brain tumors
-
Nabors M.W., Griffin C.A., Zehnbauer B.A., Hruban R.H., Phillips P.C., Grossman S.A., et al. Multidrug resistance gene (MDR1) expression in human brain tumors. J. Neurcsurg. 1991, 75:941-946.
-
(1991)
J. Neurcsurg.
, vol.75
, pp. 941-946
-
-
Nabors, M.W.1
Griffin, C.A.2
Zehnbauer, B.A.3
Hruban, R.H.4
Phillips, P.C.5
Grossman, S.A.6
-
19
-
-
34250158420
-
Identification of hypoxia-induced genes in a malignant glioma cell line (U-251) by cDNA microarray analysis
-
Ragel B.T., Couldwell W.T., Gillespie D.L., Jensen R.L. Identification of hypoxia-induced genes in a malignant glioma cell line (U-251) by cDNA microarray analysis. Neurosurg. Rev. 2007, 30:181-187.
-
(2007)
Neurosurg. Rev.
, vol.30
, pp. 181-187
-
-
Ragel, B.T.1
Couldwell, W.T.2
Gillespie, D.L.3
Jensen, R.L.4
-
20
-
-
0037431518
-
Refined mapping of 1q32 amplicons in malignant gliomas confirms MDM4 as the main amplification target
-
Riemenschneider M.J., Knobbe C.B., Reifenberger G. Refined mapping of 1q32 amplicons in malignant gliomas confirms MDM4 as the main amplification target. Int. J. Cancer 2003, 104:752-757.
-
(2003)
Int. J. Cancer
, vol.104
, pp. 752-757
-
-
Riemenschneider, M.J.1
Knobbe, C.B.2
Reifenberger, G.3
-
21
-
-
12944297139
-
Glioblastoma multiforme-report of 267 cases treated at a single institution
-
Stark A.M., Nabavi A., Mehdorn H.M., Blömer U. Glioblastoma multiforme-report of 267 cases treated at a single institution. Surg. Neurol. 2005, 63:162-169.
-
(2005)
Surg. Neurol.
, vol.63
, pp. 162-169
-
-
Stark, A.M.1
Nabavi, A.2
Mehdorn, H.M.3
Blömer, U.4
-
22
-
-
0037161024
-
Chemoyherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials
-
Stewart L.A. Chemoyherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 2002, 59:1011-1018.
-
(2002)
Lancet
, vol.59
, pp. 1011-1018
-
-
Stewart, L.A.1
-
23
-
-
79953059991
-
Regulation of glioblastoma progression by cord blood stem cells is mediated by downregulation of cyclin D1
-
Velpula K.K., Dasari V.R., Tsung A.J., Gondi C.S., Klopfenstein J.D., Mohanam S., et al. Regulation of glioblastoma progression by cord blood stem cells is mediated by downregulation of cyclin D1. PLoS One 2011, 6:e18017.
-
(2011)
PLoS One
, vol.6
-
-
Velpula, K.K.1
Dasari, V.R.2
Tsung, A.J.3
Gondi, C.S.4
Klopfenstein, J.D.5
Mohanam, S.6
-
24
-
-
47049086333
-
Targeting the epidermal growth factor receptor in high-grade astrocytomas
-
Voelzke W.R., Petty W.J., Lesser G.J. Targeting the epidermal growth factor receptor in high-grade astrocytomas. Curr. Treat. Options Oncol. 2008, 9:23-31.
-
(2008)
Curr. Treat. Options Oncol.
, vol.9
, pp. 23-31
-
-
Voelzke, W.R.1
Petty, W.J.2
Lesser, G.J.3
-
25
-
-
0011641451
-
-
Hubei Science and Technology Publishing Inc., Wuhan
-
Wang Z. Neurosurgery 2002, Hubei Science and Technology Publishing Inc., Wuhan, p. 430.
-
(2002)
Neurosurgery
, pp. 430
-
-
Wang, Z.1
-
26
-
-
68949144565
-
Upregulation of LRIG1 suppresses malignant glioma cell growth by attenuating EGFR activity
-
Ye F., Gao Q., Xu T., Zeng L., Ou Y., Mao F., et al. Upregulation of LRIG1 suppresses malignant glioma cell growth by attenuating EGFR activity. J. Neurooncol. 2009, 94:183-194.
-
(2009)
J. Neurooncol.
, vol.94
, pp. 183-194
-
-
Ye, F.1
Gao, Q.2
Xu, T.3
Zeng, L.4
Ou, Y.5
Mao, F.6
-
27
-
-
14744273305
-
The effect of cyclin D expression on cell proliferation in human gliomas
-
Zhang X., Zhao M., Huang A.Y., Fei Z., Zhang W., Wang X.L. The effect of cyclin D expression on cell proliferation in human gliomas. J. Clin. Neurosci. 2005, 12:166-168.
-
(2005)
J. Clin. Neurosci.
, vol.12
, pp. 166-168
-
-
Zhang, X.1
Zhao, M.2
Huang, A.Y.3
Fei, Z.4
Zhang, W.5
Wang, X.L.6
-
28
-
-
77953001932
-
AKT2 expression is associated with glioma malignant progression and required for cell survival and invasion
-
Zhang J., Han L., Zhang A., Wang Y., Yue X., You Y., et al. AKT2 expression is associated with glioma malignant progression and required for cell survival and invasion. Oncol. Rep. 2010, 24:65-72.
-
(2010)
Oncol. Rep.
, vol.24
, pp. 65-72
-
-
Zhang, J.1
Han, L.2
Zhang, A.3
Wang, Y.4
Yue, X.5
You, Y.6
|